Forum Replies Created
-
AuthorPosts
-
14 July 2016 at 7:12 pm in reply to: GP2U and Skinview – Diagnose melanoma at home using your phone #20926
Great idea Dr James. You excel in disruption.
Loved this bit: ‘genetically cursed with the entrepreneurial gene’
Trying to vote but it’s not responding…
11 June 2016 at 7:08 am in reply to: India Buyers Club: The new way for Americans to buy cheap drugs #18882You’re right GF – kiss kiss and kiss to all of you.
Dear Fitz – I was referring to the comments, not the articles. I assume comments are mostly written by real people?
Thanks Gaj.
Yes, those wonderful Tasmanians who stuck out their necks for all of us. Eternally grateful. Now more are taking risks to help others, and it will continue to spread. Because people care about people.
“Right now many of our community members are surviving HIV, but dying from hepatitis C,” says Aditya Wardhana, executive director of the Indonesia AIDS Coalition.
Feeling very sad about that.
Yes Matt, I share those concerns, especially since names and positions are mentioned.
With 3 million living with Hep C and even the price of generics out of range for most, let’s hope Indonesia’s National Insurance lists the new meds asap.
11 June 2016 at 3:08 am in reply to: India Buyers Club: The new way for Americans to buy cheap drugs #18859Point taken Fitz, I have removed Bigsby’s quote, which I believe was an off-hand comment on Big Pharma and the American system rather than the American people. I did not intend to offend or alienate anybody, everybody is welcome here. Credit to you for informing other Americans about this site and the way out of Hep C misery.
My gripe is with Gilead’s obscene profiteering and how they get away with it. An American company squeezing the life out of Americans. Yet from reading hundreds of comments on articles relating to DAAs I’ve been surprised at the number of Americans (without Hep C I assume) who believe Gilead’s pricing strategy is justified, and that to impose controls would deter further investment in research and development. I guess that’s all part of their marketing strategy.
There is a middle path…
20 May 2016 at 6:58 am in reply to: GT2 Honks About Generic Sofosbuvir +Daclatasvir (SOF + DCV) #17544Ratification is tied to collective GDP.
As there is significant push back in some signatory countries, it’s reasonable to assume at least one will fail to ratify the agreement. This is the mark everyone will be watching. In that event, the agreement can still come into force if at least six countries, which between them represent at least 85 percent of the total GDP of the original 12, have ratified it within two years.The TPP will truly be decided between the United States and Japan, which together represent just under 80 percent of the total GDP of the signatories. As Ankit Panda noted in October, “Basically, the TPP can’t come into force if either of these states fail to ratify the agreement in their domestic legislatures because there would be no way for the remaining signatories to fulfill the 85 percent of GDP requirement (even if the United States and all states but Japan ratify, the eleven would stand at 83 percent of GDP).”
http://thediplomat.com/2016/02/tpp-the-ratification-race-is-on/
And what happens if Indonesia and Thailand join in?
Complicated.
Feeling very happy for you Em. illy:' />
Great news GAJ, and may it continue to be….thanks for your wise words along the way.
Médecins Sans Frontières are strongly opposed to the TPP, particularly concerning generics. From a letter addressed to US Congress and co-signed by 50 other organisations concerned with public health:
Generic competition has consistently proven the most effective means of reducing prices and ensuring prices continue to fall over time. In the U.S., generic medicines have saved $1.5 trillion in health care costs in the past decade. Internationally, generics have played a critical role in responding to the AIDS epidemic, saving millions of lives and enabling people living with HIV to still realize their potential. By expanding the monopoly power of pharmaceutical companies, TPP provisions would restrict generic competition and thereby enable medicine prices to keep spiraling out of reach – locking in a broken system here at home and exporting that system to the eleven other TPP countries and those that may join later, including lower-income developing countries where public resources are limited and most people pay for medicines out-of-pocket.
http://www.msfaccess.org/content/letter-msf-and-over-50-groups-urge-us-congress-reject-tpp
TPP – signed but not ratified, and let’s hope it never is. It’s companion TPIP (between US & EU) is also in trouble after being leaked to Greenpeace this week: https://www.theguardian.com/business/2016/may/01/leaked-ttip-documents-cast-doubt-on-eu-us-trade-deal
Ariel wrote:Ariel who is still grinning like a chimpanzee
Congratulations Ariel!
-
AuthorPosts